So, the question is, as a CMO company, what should I do to attract big pharma companies to partner with me?
Questions across 3 calls
Atirek Roy
Firm not listed in source transcripts
Neuland Laboratories Limited
So my first question is considering 3 points, we hav e not lost any customer in the past. Our custom manufacturing customers patent will not expire till 2030. It is difficult to switch the supplier after the molecule gets commercialized. Will it be fair to assume that our commercialized API and intermediate count will increase quarter-on-quarter for at least 2 years?
Yes, I was talking about commercialized API, not about registration and phase one phase two API's so will our commercialized API are counting to this quarter-on-quarter.
Congrats on the good numbers. So my first question is, if I as a pharma company, wants to change or add a supplier for my commercialized drug API under patent, what is the typical steps to be followed and how much time that each step takes typically.
Commercialized drug API under patent.